Endometrial stromal sarcoma: Objective response to letrozole Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Endometrial Neoplasms
  • Neoplasm Recurrence, Local
  • Nitriles
  • Sarcoma, Endometrial Stromal
  • Triazoles

abstract

  • Letrozole at a daily dose of 2.5 mg may be effective in low-grade endometrial stromal sarcoma with positive estrogen receptors.

publication date

  • August 20, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1006/gyno.2001.6238

PubMed ID

  • 11531300

Additional Document Info

start page

  • 384

end page

  • 8

volume

  • 82

number

  • 2